Balchem Corp (OQ:BCPC)

Sector:  Basic Materials Industry:  Specialty Chemicals
 
See Regulatory Filings on SEC
Company Contact
Address: 5 Paragon Drive
MONTVALE NJ 07645
Tel: N/A
Website: https://balchem.com
IR: See website
<
Key People
Theodore L. Harris
Chairman of the Board, President, Chief Executive Officer
Martin Bengtsson
Chief Financial Officer, Executive Vice President
M. Brent Tignor
Chief Human Resource Officer, Senior Vice President
Hatsuki Miyata
Executive Vice President, General Counsel, Secretary
Michael R. Sestrick
Senior Vice President, Chief Technology Officer
Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Job L. Van Gunsteren
Senior Vice President, General Manager - Specialty Products
Jonathan H. Griffin
Senior Vice President - Corporate Development
Martin L. Reid
Senior Vice President, Chief Supply Chain Officer
Business Overview
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Financial Overview
For the three months ended 31 March 2024, Balchem Corp revenues increased 3% to $239.7M. Net income increased 28% to $29M. Revenues reflect Human nutrition & health segment increase of 15% to $152.7M, United States segment increase of 9% to $182.1M. Net income benefited from Other expense - Balancing value increase of 67% to $693K (income), Interest expense - Balancing value decrease of 3% to $5.4M (expense).
Employees: 1,302 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $5,315M as of Mar 31, 2024
Annual revenue (TTM): $929.56M as of Mar 31, 2024
EBITDA (TTM): $217.76M as of Mar 31, 2024
Net annual income (TTM): $114.82M as of Mar 31, 2024
Free cash flow (TTM): $121.67M as of Mar 31, 2024
Net Debt Last Fiscal Year: $243.38M as of Mar 31, 2024
Shares outstanding: 32,423,468 as of Apr 22, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.